Monoclonal antibodies
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Monoclonal antibodies, covering 2026-04-06 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: Human Mesenchymal Stem Cells & Monoclonal Antibodies in the Treatment for Mild Cognitive Impairment or Early Alzheimer's Disease. [Phase 2]